Skip to main content
Premium Trial:

Request an Annual Quote

BARDA Awards up to $30M to Cue Health for Influenza, Respiratory Pathogen Test Development

NEW YORK (GenomeWeb) – The US Department of Health and Human Services' Biomedical Advanced Research and Development Authority has awarded up to $30 million in funding and options to San Diego-based Cue Health to accelerate the development and regulatory validation of over-the-counter and professional-use influenza and multiplex respiratory pathogen diagnostic cartridges for its health monitoring system, the company said today.   

The monitoring system centers around an electronically connected diagnostic device that enables a range of in-home and in-clinic diagnostics, Cue Health said. It uses a custom designed reader to test clinical samples in a disposable test cartridge and then sends the results to a mobile application that provides access to features such as telemedicine consultations for consumers and prescribing capabilities for physicians. 

The firm anticipates developing an influenza cartridge to detect influenza A and B and a cartridge to detect and differentiate between multiple respiratory pathogens. 

In a separate announcement earlier this week, the firm said that it raised more than $45 million in Series B financing that it will use to complete development of its first set of diagnostic products and fund a set of clinical studies to obtain US Food and Drug Administration 510(k) clearance for them. 

According to Cue, its disposable cartridges use advanced DNA/RNA amplification and immunoassay chemistry to generate digital information that is sent to a mobile device.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.